Large-cap Health Care company Boston Scientific has logged a -1.0% change today on a trading volume of 2,804,995. The average volume for the stock is 8,399,315.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. Based in Marlborough, United States the company has 45,000 full time employees and a market cap of $76,559,851,520.
The company is now trading -14.58% away from its average analyst target price of $61.18 per share. The 28 analysts following the stock have set target prices ranging from $55.0 to $68.0, and on average give Boston Scientific a rating of buy.
Over the last 52 weeks, BSX stock has risen 25.0%, which amounts to a 10.0% difference compared to the S&P 500. The stock's 52 week high is $55.38 whereas its 52 week low is $40.95 per share. With its net margins declining an average -14.1% over the last 6 years, Boston Scientific may not have a strong enough profitability trend to support its stock price.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 13,400,000 | 912,000 | 7 | 16.67 |
| 2022 | 12,682,000 | 698,000 | 6 | -33.33 |
| 2021 | 11,888,000 | 1,041,000 | 9 | 1000.0 |
| 2020 | 9,913,000 | -82,000 | -1 | -102.27 |
| 2019 | 10,735,000 | 4,700,000 | 44 | 158.82 |
| 2018 | 9,823,000 | 1,671,000 | 17 |
